Background: Contrast-induced acute kidney
injury (CI-AKI) representing the third most common cause of hospital acquired
AKI. As serum creatinine (SCr) is an unreliable indicator of acute changes in
renal function thus the need for early sensitive biomarkers to detect AKI of
utmost value. Urinary Liver type fatty acid binding protein (uL-FABP) and
plasma Cystatin C (CysC) is a newly emerging ones. Objective: To evaluate the
significance of urinary L-FABP and plasma Cystatin as early prediction
biomarkers of contrast induced AKI. Patients and methods: This study comprised
a total of 33 patients divided into two main groups; Group I: 16 patients
underwent coronary angiography for diagnostic and therapeutic purposes and
Group II: 17 patients underwent computerized tomography (CT) for various
purposes using intravenous (IV) contrast (high osmolar) media (CM). Then the
patients reclassified into 2 new subgroups; AKI and non AKI groups accordinting
to the change in SCr 24 hours (hs) after CM administration. Full clinical
examination, routine investigations and estimation of urinary L-FABP and p-
CysC were done. Results: the basal value of urinary L-FABP and p-CysC was
significantly higher in AKI versus non AKI groups. AUC of u L-FABP = 0.837
(95%CI; 0.673 ? 1.001); AUC of p-CysC = 0.742 (95%CI; 0.600 ? 0.925). Six hs
post contrast, both p- CysC and urinary L-FABP showed a highly statistically
significant elevation at 6 hours in AKI group as compared to non AKI group,
while there was no statistically significant difference in SCr, which showed
significant elevation only after 24 hours. AUC of urinary L-FABP =1 (95%CI; 1 ?
1); AUC of p-CysC =1 (95%CI; 1 ? 1).There was significant positive correlation
between uL-FABP and both p-CysC and amount of IV contrast (r=0.59, p<0.05
&r =0.53, p<0.05) respectively, negative correlation regarding estimated
glomerular filtration rate (eGFR) (r=-0.52, p <0.5), whereas no significant
correlations regarding SCr. Twenty four hs post contrast ,there was significant
positive correlations between uL-FABP and each of p- CysC, contrast volume and
SCr(r=0.61, p<0.05, r= 0.56,p<0.05, &r=0.58, p<0.05) respectively
, but negative correlation regarding eGFR(r=-0.52, p<0.05) in AKI group.
Conclusion: Urinary L-FABP and plasma Cystatin C can be considered as
predictive biomarkers of contrast induced nephropathy (AKI), basally before
contrast exposure and as early as six hours post contrast administration
instead of serum creatinine, clearly, as these biomarkers levels start to rise
earlier and in advance before any significant change in serum creatinine. - Seemore at:
No comments:
Post a Comment